Enhancer-associated regulatory network and gene signature based on transcriptome and methylation data to predict the survival of patients with lung adenocarcinoma.

Front Genet · 2022 · PMC9538943 · PMID 36212131

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

In our study, the comprehensive multi-omics analysis has also been applied to screen the target genes, which may be significant to prognosis prediction of lung cancer.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.